Assessment of serological assays for identifying high titer convalescent plasma

Mostrar otras versiones (1)

BACKGROUND: The COVID‐19 pandemic has been accompanied by the largest mobilization of therapeutic convalescent plasma (CCP) in over a century. Initial identification of high titer units was based on dose–response data using the Ortho VITROS IgG assay. The proliferation of severe acute respiratory sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Farnsworth, Christopher W., Case, James B., Hock, Karl, Chen, Rita E., O'Halloran, Jane A., Presti, Rachel, Goss, Charles W., Rauseo, Adriana M., Ellebedy, Ali, Theel, Elitza S., Diamond, Michael S., Henderson, Jeffrey P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Blood Donors and Blood Collection
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440373/
https://www.ncbi.nlm.nih.gov/pubmed/34216156
http://dx.doi.org/10.1111/trf.16580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440373/
https://www.ncbi.nlm.nih.gov/pubmed/34216156
http://dx.doi.org/10.1111/trf.16580

Ejemplares similares